Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08NJF
|
||||
Former ID |
DCL000948
|
||||
Drug Name |
Radaxafine HCl
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Neuropathic pain [ICD9: 356.0, 356.8; ICD10:G64, G90.0] | Discontinued in Phase 1 | [536374] | ||
Therapeutic Class |
Analgesics
|
||||
Company |
GlaxoSmithKline
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H26Cl2N2O4
|
||||
Canonical SMILES |
C1CCC2(C1)CCN(CC2)C(=O)C(CCC(=O)O)NC(=O)C3=CC(=CC(=C3)C<br />l)Cl
|
||||
InChI |
1S/C21H26Cl2N2O4/c22-15-11-14(12-16(23)13-15)19(28)24-17(3-4-18(26)27)20(29)25-9-7-21(8-10-25)5-1-2-6-21/h11-13,17H,1-10H2,(H,24,28)(H,26,27)/t17-/m1/s1
|
||||
InChIKey |
FJCZHMXAGBYXHJ-QGZVFWFLSA-N
|
||||
CAS Number |
CAS 106083-71-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Dopamine reuptake | Target Info | Inhibitor | [536374] | |
Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [536374] | ||
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.